Nkiliza, Aurore, Parks, Megan, Cseresznye, Adam et al. · Journal of translational medicine · 2021 · DOI
This study analyzed fatty substances in the blood of ME/CFS patients and healthy controls to see if they differ in ways that might explain symptoms. Researchers found that men and women with ME/CFS had different patterns of these blood fats compared to healthy people. Importantly, certain blood fats were connected to the severity of fatigue, headaches, and thinking difficulties, suggesting that problems with how the body processes fats may play a role in ME/CFS symptoms.
This research provides evidence that ME/CFS involves dysregulated lipid metabolism, which may contribute to the characteristic symptoms of fatigue, pain, and cognitive impairment. Identifying biological markers like abnormal blood lipids could eventually lead to better diagnostic tools and targeted treatments for ME/CFS. The sex-specific differences discovered are particularly important given that ME/CFS affects more women than men.
This study cannot prove that abnormal lipids cause ME/CFS symptoms—it only shows they are associated. The cross-sectional design means we cannot determine whether lipid changes precede symptom development or result from having the illness. Additionally, findings in this relatively small cohort require replication in larger, more diverse populations before clinical application.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.